|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:918-919
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Department of Cardiac Surgery, Children's Hospital and Harvard Medical School, Boston, Mass.
Requested for publication Nov 1, 1998Received March 5, 1999. Accepted for publication March 8, 1999. Address for reprints: Pedro J. del Nido, MD, Department of Cardiac Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA 02115.
| Introduction |
|---|
|
|
|---|
In children, one additional variable needs to be considered: DCM does not progress in a significant proportion of infants and children, and some undergo spontaneous recovery. Indeed, spontaneous recovery of LV function in as high as 45% of cohorts has been noted.
5 Several reports have addressed the problem of predicting outcome in children with DCM. Most reports with larger series (>20 patients) have found that older age at presentation and the presence of fibroelastosis are strong predictors of poor outcome.
6,7 Other reported risk factors include the presence of a mural thrombus and a spherical shape to the LV.
5 Of the children who do recover, most have definite improvement in LV function within 3 months. However, those with progressive dilatation or ventricular arrhythmias are at high risk for early death.
Two case reports published in this Journal describe the results with partial left ventriculectomy in children with severe LV dysfunction and dilatation. Berger and associates
8 report a case of a 3-day-old infant with unexplained LV dysfunction and severe mitral regurgitation in whom systemic perfusion was maintained by the right ventricle via the patent arterial duct. Partial left ventriculectomy and mitral valve repair were associated with gradual recovery at 8 months' follow-up. Histologic examination of the excised tissue was reported as not showing a specific abnormality. In a previous report, Yoshii and colleagues
9 described a 5-month-old infant with LV dysfunction and dilatation progressing over a 2-month period, associated with severe mitral regurgitation, endocardial fibroelastosis, and endomyocardial biopsy with no abnormality. This infant also underwent partial ventriculectomy with mitral valve repair, and histologic examination showed endomyocardial fibrous thickening. Improved LV function was noted at 1 month's follow-up.
These reports illustrate some of the problems surgeons face in deciding treatment of children with DCM. In the first case, although LV function was severely depressed, determining the prognosis was difficult because of the scarcity of experience in managing neonates with DCM. Whether continued inotropic support and prostaglandins to maintain ductal patency would have resulted in a similar outcome is not known. Mitral insufficiency, although severe, may also have recovered along with LV function, as is frequently seen in infants after repair of anomalous origin of the left coronary artery from the pulmonary artery. Unfortunately, because of the lack of experience with neonatal DCM, each surgeon is left to decide management on the basis of available resources and personal experience.
In the second case, the progression of LV dilatation, despite treatment with vasodilators and inotropic agents and evidence of endocardial fibroelastosis, predicted a very poor prognosis. The early favorable results with ventriculectomy and mitral valve repair are encouraging. However, early redilatation of the LV may still be seen in this patient, as has been reported in larger series of adult patients.
Because of the low incidence of DCM in children and the heterogeneous approach to their management among many centers, it is unlikely that any one pediatric center will accumulate sufficient experience with partial ventriculectomy to determine which patients are the best candidates. Unless a coordinated multicenter effort is made to study patients prospectively, we will need to rely on the growing experience with this procedure in adult patients to guide decisions about patient selection and operative technique. For now, each center will need to evaluate potential candidates individually on the basis of carefully assessed and known prognostic factors in children and the availability and results of alternative treatments such as transplantation.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. D. Mainwaring, R. M. Healy, J. D. Murphy, and W. I. Norwood Norwood/Batista operation for a newborn with dilated myopathy of the left ventricle J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 612 - 615. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |